CureDM Partners Novel Diabetes Treatment with Sanofi-Aventis.

Business WireApril 08, 2010

Linked as:

Extract


CureDM Partners Novel Diabetes Treatment with Sanofi-Aventis.

WILMINGTON, Del. -- CureDM, LLC announced today that an agreement has been signed with Sanofi-Aventis (EURONEXT: SAN and NYSE: SNY) for the exclusive worldwide license of Pancreate[TM...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company